Yong‐Xin Li

This study identifies health-associated gut bacteriocins that target TLR4 to suppress intestinal inflammation in murine models.

The paper introduces IIBacFinder to identify unmodified class II bacteriocins in the human gut microbiome, showing their widespread distribution and biosynthetic potential.

This paper identifies twenty-four new archaeal lanthipeptides with unique chemical features and ecological functions, expanding the known chemical diversity of archaeal secondary metabolites.

This study identifies diverse ribosomally synthesized peptides in the human microbiome and shows some inhibit pathogens and reduce inflammation.

This study identifies a gut microbiome-derived peptide that mimics a myelin antigen and induces experimental autoimmune encephalomyelitis in mice.

This paper identifies a versatile P450 enzyme, GpeC, capable of catalyzing peptide biaryl macrocyclization across diverse substrates and demonstrates its application in synthesizing natural products.

This study discovers new Avi(Me)Cys-containing cyclopeptide antibiotics effective against drug-resistant bacteria using genome mining and metabolomics.

The paper identifies diverse antagonistic bacteriocins from lactic acid bacteria in the human microbiome using metagenomic and metatranscriptomic analysis.